MedPath

Analysis of Red Blood Cell Integrity and Efficiency of Recovery Using a Novel Surgical Sponge-Blood Recovery Device (ProCell): Delayed Impact

Not Applicable
Withdrawn
Conditions
Blood Recovery
Interventions
Procedure: Hand Wrung
Device: ProCell Wrung
Registration Number
NCT05545956
Lead Sponsor
University Hospitals Cleveland Medical Center
Brief Summary

The purpose of this research study is to compare two methods of recovering blood from surgical sponges used during heart and lung surgeries. The two methods are: 1) manually wringing sponges by hand, and 2) automated wringing sponges by an FDA approved suction device. Both methods are already in use in heart and lung surgeries at University Hospitals at the discretion of the surgeon.

Detailed Description

Not available

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
22
Inclusion Criteria
  • Undergoing heart or lung transplant, redo sternotomy, aortic surgery, and/or multi-valve repairs/replacements; and
  • At University Hospitals Cleveland Medical Center.
Exclusion Criteria
  • Patients with known bleeding disorders, including disseminated intravascular coagulation (DIC), prothrombin deficiency, factor V deficiency, factor VII deficiency, factor X deficiency, factor XI deficiency (hemophilia C), Glanzmann disease, hemophilia A, hemophilia B, idiopathic thrombocytopenic purpura (ITP), and Von Willebrand disease (types I, II, and III);
  • Patients undergoing emergent or emergent salvage surgery; and
  • Patients actively participating in another clinical trial which could affect outcomes.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Hand WrungHand WrungHand wrung refers to manually wringing surgical sponges by hand.
ProCell WrungProCell WrungProCell wrung refers to automated wringing surgical sponges by an FDA approved suction device (ProCell).
Primary Outcome Measures
NameTimeMethod
Units of Packed Red Blood Cells TransfusedUp to 72 Hours Post-Operative

Units of packed red blood cells transfused will be measured.

Change in Level of HematocritBaseline, Post-Operative Hours 0, 6, 12, 18, 24, 48, and 72

Level of hematocrit will be measured at baseline and post-operative.

Change in Level of Plasma Free HemoglobinBaseline, Post-Operative Hours 0, 6, 12, 18, 24, 48, and 72

Level of plasma free hemoglobin will be measured at baseline and post-operative.

Change in Volume of BloodBaseline, Post-Processing (Up to 120 Minutes)

Volume of blood will be measured at baseline and post-processing.

Secondary Outcome Measures
NameTimeMethod
Change in Number of Fragmented Red Blood CellsBaseline, Post-Operative Hours 0, 6, 12, 18, 24, 48, and 72

Number of fragmented red blood cells will be measured at baseline and post-operative.

Change in Level of Lactate DehydrogenaseBaseline, Post-Operative Hours 0, 6, 12, 18, 24, 48, and 72

Level of lactate dehydrogenase will be measured at baseline and post-operative.

Change in Level of HaptoglobinBaseline, Post-Operative Hours 0, 6, 12, 18, 24, 48, and 72

Level of haptoglobin will be measured at baseline and post-operative.

Time to Wring SpongesUp to 120 Minutes

Time in seconds to wring sponges will be measured.

Change in Level of BilirubinBaseline, Post-Operative Hours 0, 6, 12, 18, 24, 48, and 72

Level of bilirubin will be measured at baseline and post-operative.

Change in Weight of Surgical SpongeBaseline, Post-Procedure (Up to 5 Minutes)

Weight of surgical sponges will be measured at baseline and post-procedure.

Trial Locations

Locations (1)

University Hospitals Cleveland Medical Center

🇺🇸

Cleveland, Ohio, United States

© Copyright 2025. All Rights Reserved by MedPath